SCHEMBL17280113

SCHEMBL17280113

CCOC(=O)Oc1ccc(-c2nc(-c3cccc(-c4n[nH]c(-c5ccc(OC(=O)OCC)cc5)n4)c3)n[nH]2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 5/20 0.50
▸ NR1H3 Q13133 5/20 0.50
▸ S1PR1 P21453 1/20 0.46
▸ ADORA2A P29274 2/20 0.45
▸ ADORA1 P30542 2/20 0.45
▸ LMNA P02545 2/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ ATAD2 Q6PL18 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TP53 P04637 1/20 0.43
▸ GRK6 P43250 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17280112 0.85 NR1H2 (0.52) NR1H2NR1H3S1PR1ADORA2AADORA1
SCHEMBL17280115 0.83 NR1H2 (0.50) NR1H2NR1H3S1PR1ADORA2AADORA1
SCHEMBL17280110 0.81 LMNA (0.46) NR1H2NR1H3S1PR1ADORA2ALMNA
SCHEMBL17280225 0.80 KMT2A (0.40) LMNARAB9ANPC1MEN1MAPT
SCHEMBL17280111 0.79 GAA (0.47) NR1H2NR1H3S1PR1ADORA2AADORA1
SCHEMBL17279736 0.79 LMNA (0.51) NR1H2NR1H3ADORA2AADORA1LMNA
SCHEMBL17279975 0.77 MAPT (0.48) RAB9ANPC1MEN1ALDH1A1MAPT
SCHEMBL17280116 0.77 NR1H2 (0.60) NR1H2NR1H3ADORA2AADORA1RAB9A
SCHEMBL17280052 0.76 NPC1 (0.56) NR1H2NR1H3S1PR1ADORA2AADORA1
SCHEMBL17280098 0.75 MAPT (0.54) NR1H2NR1H3ADORA2AADORA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020149206-A1 METHOD FOR PRODUCING ACRYLIC RESIN FILM コニカミノルタ株式会社 2020-07-23 — — WO disclosed
US-20180203175-A1 TRIAZOLE COMPOUND Konica Minolta, Inc. (JP) 2018-07-19 — — US disclosed
US-20180203175-A1 TRIAZOLE COMPOUND Konica Minolta, Inc. (JP) 2018-07-19 — — US disclosed
US-10012777-B2 Resin composition Konica Minolta, Inc. (JP) 2018-07-03 — — US disclosed
US-10012777-B2 Resin composition Konica Minolta, Inc. (JP) 2018-07-03 — — US disclosed
WO-2017099041-A1 POLYIMIDE FILM, FLEXIBLE PRINTED BOARD, LED LIGHTING DEVICE ETC. コニカミノルタ株式会社 2017-06-15 — — WO disclosed
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE KONICA MINOLTA, INC (JP) 2015-11-26 — — US disclosed
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE KONICA MINOLTA, INC (JP) 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE HRH3, HELZ, NBAS NR1H2 1059/4885NR1H3 766/4885S1PR1 4694/4885
US-10012777-B2 Resin composition NBAS, WDR5, HRH3 NR1H2 1877/4885NR1H3 1458/4885S1PR1 4754/4885
US-20180203175-A1 TRIAZOLE COMPOUND H1-10, TTI2, H1-2 NR1H2 534/4885NR1H3 787/4885S1PR1 2814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback